2012 Meetings

November 2012 Meeting:

AGAR Executive Minutes Nov 2012 (PDF)
November 2012 AGAR Exec Agenda (PDF)
Proposed 2013 Operating Procedures (PDF)
Attachment 1. AGAR June 2012 Financial Report (PDF)
Attachment 2. 2011/2012 Financial Report (PDF)
Attachment 3. September 2012 Financial Quarter (PDF)
Attachment 4. 2010 Ertapenem Financial Report (PDF)
Attachment 5. 2011 Ertapenem Financial Report (PDF)
Attachment 6. 2011 Ceftaroline Financial Report (PDF)
Attachment 7. AGAR 2010/2011 AGAR Funding (PDF)
Attachment 8. 2011/2012 AGAR Funding (PDF)
Attachment 9. Initial Funding Request (PDF)
Attachment 10. Revised Funding Request (PDF)
Attachment 11. DoH Letter of Offer (PDF)
Attachment 12. Contract 2012/2013 to 2014/2015 (PDF)
Attachment 13. NEAF (PDF)
Attachment 14. AESOP Protocol (PDF)
Attachment 15. AESOP Data Fields (PDF)
Attachment 16. 2012/2013-2015/2016 Proposed Data Collection Fields (PDF)
Attachment 17. MSD 2011 Ertapenem Report (PDF)
Attachment 18. AstraZeneca 2011 Ceftaroline Report (PDF)
Attachment 19. AMRAU Project (PDF)

May 2012 Meeting:

Executive Agenda (PDF)
AGAR Executive Minutes – May 2012 (PDF)
Attachment 1: Audited 2010 2011 Report (PDF)
Attachment 2: December 2011 Financial Report (PDF)
Attachment 3: March 2012 Financial Report (PDF)
Attachment 4: 2010 Ertapenem Financial Report (PDF)
Attachment 5: 2011 Ertapenem Financial Report (PDF)
Attachment 6: 2011 2012 Budget (PDF)
Attachment 7: Health Surveillance Fund Guidelines (PDF)
Attachment 8: EARS-Net Protocol (PDF)

Copyright © 2004-2022 Australian Group on Antimicrobial Resistance (AGAR). Last Updated December 2017.